Skip to main content

Lucira Health, Inc.

LHDXDelisted Apr 12, 2023
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0001652724

Lucira Health, Inc. was delisted on Apr 12, 2023; its insiders filed their last Form 4 on Mar 13, 2023; 29 institutions reported holding it in 13F filings for Q4 2022, worth $1.04M in total; no superinvestor held it.

Q4 2023 vs. Q3 2023

How the institutions holding Lucira Health, Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of LHDX: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders01+1
Shares022.8K+22.8K
Value$0$321+$321

New holders (1)

Institutions that held Lucira Health, Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to LHDX in Q4 2023
InstitutionSharesValue% of portfolio
Resolute Partners Group22,800$3210.00%

Sold out (0)

Institutions that held Lucira Health, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.

None.